Latest filing published 15 Oct 2026 for Gilead Sciences, INC., €418k.
Insider track record
Andrew Dickinson: trading record in brief
All filings by Andrew Dickinson on record concern Gilead Sciences, Inc. We count 5 filings; the first trade dates from 15 June 2026 and the latest from 15 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 15 October 2026, the filings show a transaction worth €418k in Gilead Sciences, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Dickinson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$156.22CommonSEC144:0001950047-26-010246
- 3,000 shares@ US$145.290.0002% mcap27.0% of flowCommonSEC144:0001950047-26-009467
- 3,000 shares@ US$138.360.0002% mcap25.6% of flowCommonSEC144:0001950047-26-008208
- 3,000 shares@ US$129.92560.0002% mcap24.3% of flowCommonSEC144:0001950047-26-007091
- 3,000 shares@ US$125.400.0002% mcap23.2% of flowCommonSEC144:0001950047-26-006086
5 of 5 declarations
